Futura Medical is a pharmaceutical group that develops innovative products for both the prescription and consumer healthcare markets.
Futura Medical announced on 4 January the publication of positive data from its Phase II clinical trial of MED2002* in erectile dysfunction ("ED") in the peer-reviewed Journal of Sexual Medicine. This attracted much coverage in mainstream media. Read more.
*MED2002 is the codename used by Futura Medical. The final formulation for use in ongoing clinical trials is MED2005, the codename used for MED2002 in the recent published scientific literature.